4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-064102
Chief Scientific Officer acquired 20,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-12-21 | Option exercise | +20,500 | $2.34 | $47,919 | 24,637 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-12-21 | Option exercise · Stock option (right to buy) | −20,500 | 7,218 | D | ||
Loading xslF345X03/doc4.xml…